Integer Holdings Co. (NYSE:ITGR) Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. lowered its position in Integer Holdings Co. (NYSE:ITGR - Free Report) by 36.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,954 shares of the medical equipment provider's stock after selling 9,296 shares during the quarter. Russell Investments Group Ltd.'s holdings in Integer were worth $1,581,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Blue Trust Inc. increased its holdings in shares of Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider's stock worth $45,000 after buying an additional 377 shares during the last quarter. Van ECK Associates Corp boosted its holdings in shares of Integer by 22.0% in the 3rd quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider's stock worth $136,000 after purchasing an additional 313 shares in the last quarter. Strs Ohio increased its position in shares of Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider's stock valued at $168,000 after purchasing an additional 600 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in Integer in the third quarter worth approximately $182,000. Finally, Mackenzie Financial Corp bought a new position in Integer during the fourth quarter valued at approximately $204,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. Bank of America upgraded shares of Integer from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. Benchmark reaffirmed a "buy" rating and issued a $130.00 target price on shares of Integer in a research note on Friday, May 10th. Truist Financial initiated coverage on shares of Integer in a report on Wednesday. They issued a "buy" rating and a $137.00 price target on the stock. KeyCorp raised their target price on Integer from $123.00 to $139.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 9th. Finally, CL King initiated coverage on Integer in a research report on Thursday, March 14th. They issued a "buy" rating and a $137.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $128.67.

Insider Activity at Integer

In other news, VP Tommy P. Thomas sold 1,500 shares of the business's stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total value of $171,000.00. Following the sale, the vice president now directly owns 2,813 shares of the company's stock, valued at approximately $320,682. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Integer news, SVP Andrew Senn sold 5,000 shares of Integer stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total value of $565,700.00. Following the completion of the transaction, the senior vice president now directly owns 4,658 shares of the company's stock, valued at $527,006.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Tommy P. Thomas sold 1,500 shares of the company's stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the completion of the transaction, the vice president now owns 2,813 shares in the company, valued at approximately $320,682. The disclosure for this sale can be found here. Insiders sold a total of 6,812 shares of company stock valued at $771,956 in the last three months. Company insiders own 2.00% of the company's stock.

Integer Stock Up 1.6 %

Shares of ITGR stock traded up $1.92 during midday trading on Friday, reaching $120.92. 356,772 shares of the stock were exchanged, compared to its average volume of 334,141. Integer Holdings Co. has a 1 year low of $69.40 and a 1 year high of $123.99. The firm has a market cap of $4.05 billion, a PE ratio of 41.84, a price-to-earnings-growth ratio of 1.74 and a beta of 1.12. The company's 50 day moving average is $114.87 and its two-hundred day moving average is $103.47. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.02. The company had revenue of $414.80 million for the quarter, compared to analysts' expectations of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The firm's revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.87 earnings per share. On average, equities research analysts predict that Integer Holdings Co. will post 5.27 EPS for the current year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.